The Journal of Practical Medicine ›› 2025, Vol. 41 ›› Issue (5): 657-663.doi: 10.3969/j.issn.1006-5725.2025.05.006
• Basic Research • Previous Articles
Lifei HE1,Lin ZHU1(),Feng XUE2,Zuyue BI1,Zhaoxin. LI1
Received:
2024-10-23
Online:
2025-03-10
Published:
2025-03-20
Contact:
Lin ZHU
E-mail:doctor_zl0301@163.com
CLC Number:
Lifei HE,Lin ZHU,Feng XUE,Zuyue BI,Zhaoxin. LI. Effects of LINC01772 on cell cycle, apoptosis and radiosensitivity of A549[J]. The Journal of Practical Medicine, 2025, 41(5): 657-663.
Tab.1
Interference sequence of LINC01772"
名称 | ShRNA序列(5′-3′) |
---|---|
Shlinc-1# | CCGGCTAGACCTGTGACTGCTAACCCTCGAGGGTTAGCAGTCACAGGTCTAGTTTTTT |
Shlinc-2# | CCGGGGACATGGTGGACATCACACACTCGAGTGTGTGATGTCCACCATGTCCTTTTTT |
Shlinc-3# | CCGGTGTTCTCCCTTCTATACAATGCTCGAGCATTCTATAGAAGGGAGAACATTTTTT |
Shlinc-4# | CCGGGGAGCAAGGGACAGCTTGATGCTCGAGCATCAAGCTGTCCCTTGCTCCTTTTTT |
1 |
SIEGEL R L, MILLER K D, WAGLE N S, et al. Cancer statistics, 2023[J]. CA Cancer J Clin, 2023, 73(1):17-48. doi:10.3322/caac.21763
doi: 10.3322/caac.21763 |
2 |
OUDKERK M, LIU S, HEUVELMANS M A, et al.Lung cancer LDCT screening and mortality reduction-evidence, pitfalls and future perspectives[J].Nat Rev Clin Oncol, 2021, 18(3):135-151. doi:10.1038/s41571-020-00432-6
doi: 10.1038/s41571-020-00432-6 |
3 |
YANG W C, HSU F M, YANG P C. Precision radiotherapy for non-small cell lung cancer[J]. J Biomed Sci, 2020, 27(1):82. doi:10.1186/s12929-020-00676-5
doi: 10.1186/s12929-020-00676-5 |
4 |
VINOD S K, HAU E. Radiotherapy treatment for lung cancer: Current status and future directions[J]. Respirology, 2020, 25 :61-71. doi:10.1111/resp.13870
doi: 10.1111/resp.13870 |
5 |
SUWA T, KOBAYASHI M, NAM J M, et al. Tumor microenvironment and radioresistance[J]. Exp Mol Med, 2021, 53(6):1029-1035. doi:10.1038/s12276-021-00640-9
doi: 10.1038/s12276-021-00640-9 |
6 |
ZHOU T, ZHANG L Y, HE J Z, et al. Review: Mechanisms and perspective treatment of radioresistance in non-small cell lung cancer[J].Front Immunol, 2023, 14:1133899. doi:10.3389/fimmu.2023.1133899
doi: 10.3389/fimmu.2023.1133899 |
7 |
TENG P C, LIANG Y, YARMISHYN A A, et al. RNA Modifications and Epigenetics in Modulation of Lung Cancer and Pulmonary Diseases[J]. Int J Mol Sci, 2021, 22(19):10592. doi:10.3390/ijms221910592
doi: 10.3390/ijms221910592 |
8 |
KHAN R I N, MALLA W A. m6A modification of RNA and its role in cancer, with a special focus on lung cancer[J]. Genomics, 2021, 113(4):2860-2869. doi:10.1016/j.ygeno.2021.06.013
doi: 10.1016/j.ygeno.2021.06.013 |
9 |
LIU H, ZHEN G W, CHEN Q, et al. lncRNA CASC19Contributes to Radioresistance of Nasopharyngeal Carcinoma by Promoting Autophagy via AMPK-mTOR Pathway[J].Int J Mol Sci, 2021, 22(3):1407. doi:10.3390/ijms22031407
doi: 10.3390/ijms22031407 |
10 |
LEI C, LI S, FAN Y, et al. LncRNA DUXAP8 induces breast cancer radioresistance by modulating the PI3K/AKT/mTOR pathway and the EZH2-E-cadherin/RHOB pathway[J].Cancer Biol Ther, 2022, 23(1):1-13. doi:10.1080/15384047.2022.2132008
doi: 10.1080/15384047.2022.2132008 |
11 |
SU H B, FAN G Z, HUANG J,et al. LncRNA HOXC-AS3 promotes non-small-cell lung cancer growth and metastasis through upregulation of YBX1[J]. Cell Death Dis, 2022, 13(4):307. doi:10.1038/s41419-022-04723-x
doi: 10.1038/s41419-022-04723-x |
12 | 蒙冲, 谢甜, 陈永倖. lncRNA CASC7靶向下调miR-181a-2-3p表达影响非小细胞肺癌细胞增殖、凋亡、迁移和侵袭[J]. 中国免疫学杂志, 2021, 37(19): 2327-2331+2337. |
13 |
LIU S, ZHAN N, GAO C. Long noncoding RNA CBR3-AS1 mediates tumorigenesis and radiosensitivity of non-small cell lung cancer through redox and DNA repair by CBR3-AS1 /miR-409-3p/SOD1 axis[J]. Cancer Lett, 2022, 526:1-11. doi:10.1016/j.canlet.2021.11.009
doi: 10.1016/j.canlet.2021.11.009 |
14 |
WU A, TANG J, DAI Y, et al. Downregulation of Long Noncoding RNA CRYBG3 Enhances Radiosensitivity in Non-Small Cell Lung Cancer Depending on p53 Status[J]. Radiat Res, 2022, 198(3):297-305. doi:10.1667/rade-21-00197.1
doi: 10.1667/rade-21-00197.1 |
15 |
TONG M A, WANG F, WANG X. LncRNA LINC01772 promotes metastasis and EMT process in cervical cancer by sponging miR-3611 to relieve ZEB1[J]. BIOCELL, 2019, 43(3):191-198. doi:10.32604/biocell.2019.06989
doi: 10.32604/biocell.2019.06989 |
16 | 张德慧,严雨姮. 长链非编码RNA LINC01772在肝细胞肝癌中的表达及临床意义[J]. 健康必读,2018, 36 (12):120. |
17 |
WANG P, GUO Q, GAO Y, et al. Improved method for prioritization of disease associated lncRNAsbased on ceRNA theory and functional genomics data[J]. Oncotarget, 2017, 8(3):4642-4655. doi:10.18632/oncotarget.13964
doi: 10.18632/oncotarget.13964 |
18 | 张洪岩,刘欢,朱宝杰,等. 余甘子提取物调控LINC01772/miR-153对肺癌细胞A549生物学行为的影响[J]. 现代生物医学进展,2024,24(5):841-848. |
19 |
YANG H, LIU Y, CHEN L,et al. MiRNA-Based Therapies for Lung Cancer: Opportunities and Challenges?[J]. Biomolecules, 2023, 13(6):877. doi:10.3390/biom13060877
doi: 10.3390/biom13060877 |
20 |
JIANG G, YU H, LI Z, et al. lncRNA cytoskeleton regulator reduces non-small cell lung cancer radiosensitivity by downregulating miRNA-206 and activating prothymosin α[J]. Int J Oncol, 2021, 59(5):88. doi:10.3892/ijo.2021.5268
doi: 10.3892/ijo.2021.5268 |
21 |
HU Q, MA H, CHEN H,et al. LncRNA in tumorigenesis of non-small-cell lung cancer: From bench to bedside[J]. Cell Death Discov, 2022, 8(1):359. doi:10.1038/s41420-022-01157-4
doi: 10.1038/s41420-022-01157-4 |
22 |
ENTEZARI M, GHANBARIRAD M, TAHERIAZAM A,et al.Long non-coding RNAs and exosomal lncRNAs: Potential functions in lung cancer progression, drug resistance and tumor microenvironment remodeling[J]. Biomed Pharmacother, 2022, 150:112963. doi:10.1016/j.biopha.2022.112963
doi: 10.1016/j.biopha.2022.112963 |
23 |
LI J, GUO S, LI T,et al. Long non-coding RNA CCAT1 acts as an oncogene to promote radiation resistance in lung adenocarcinoma: An epigenomics-based investigation[J]. Funct Integr Genomics, 2024, 24(2):52. doi:10.1007/s10142-024-01330-1
doi: 10.1007/s10142-024-01330-1 |
24 |
WANG L, CAO L, WEN C, et al. LncRNA LINC00857 regulates lung adenocarcinoma progression, apoptosis and glycolysis by targeting miR-1179/SPAG5 axis[J]. Hum Cell, 2020, 33(1):195-204. doi:10.1007/s13577-019-00296-8
doi: 10.1007/s13577-019-00296-8 |
25 | 廖志伟,朱建曼,周同冲,等. 长链非编码RNA TUG1对鼻咽癌细胞生物学行为及放射敏感性的影响[J]. 实用医学杂志,2023,39(2):209-216. |
26 | 郑杰灵,袁亚维. 脑胶质瘤中长链非编码RNA TCONS_00008552 促进放疗抵抗、侵袭转移的机制[J]. 实用医学杂志,2019,35(11):1748-1752. |
27 |
HE Y M, JIANG X L, DUAN L C, et al. LncRNA PKMYT1AR promotes cancer stem cell maintenance in non-small cell lung cancer via activating Wnt signaling pathway[J]. Mol Cancer, 2021, 20(1):156. doi:10.1186/s12943-021-01469-6
doi: 10.1186/s12943-021-01469-6 |
28 |
LIU J, JIANG M, GUAN J, et al. LncRNA KCNQ1OT1 enhances the radioresistance of lung squamous cell carcinoma by targeting the miR-491-5p/TPX2-RNF2 axis[J]. J Thorac Dis, 2022, 14(10):4081-4095. doi:10.21037/jtd-22-1261
doi: 10.21037/jtd-22-1261 |
29 | 陈联,陈学诚. 长链非编码RNA01535靶向微小RNA-483-3p调控肺癌细胞增殖和凋亡的机制研究[J]. 中国临床药理学杂志,2022,38(20):2429-2433. |
30 |
WANG Z, LIU L, DU Y, et al. The HNF1A-AS1/miR-92a-3p axis affects the radiosensitivity of non-small cell lung cancer by competitively regulating the JNK pathway[J]. Cell Biol Toxicol, 2021, 37(5):715-729. doi:10.1007/s10565-021-09595-z
doi: 10.1007/s10565-021-09595-z |
31 |
HUANG Y, TIAN Y, ZHANG W, et al. Rab12 Promotes Radioresistance of HPV-Positive Cervical Cancer Cells by Increasing G2/M Arrest[J]. Front Oncol, 2021, 11:586771. doi:10.3389/fonc.2021.586771
doi: 10.3389/fonc.2021.586771 |
32 | 朱志文,阳亮芳,郑杨,等. 周期蛋白依赖激酶抑制因子3通过调控G2/M期检查点促进肝内胆管癌细胞生长并降低对顺铂的敏感性[J]. 实用医学杂志,2022,38(22):2768-2773+2779. |
[1] | Hao WANG,Xiaoyi LU,Wenjie. WANG. Clinical efficacy of concurrent chemoradiotherapy followed by sequential sintilimab immunotherapy in elderly patients with locally advanced esophageal cancer [J]. The Journal of Practical Medicine, 2025, 41(3): 365-370. |
[2] | Xiuting HUANG,Jie LIN,Xiaoxin YE,Jiazuo CAI,Yawei. YUAN. Copper regulates the radiosensitivity of nasopharyngeal carcinoma by activating MAPK-ERK signaling pathway [J]. The Journal of Practical Medicine, 2024, 40(9): 1191-1196. |
[3] | Haiying WANG,Kai WU,Yinchun. TIAN. Association of serum MMP⁃9, CYRFA21⁃1, and VEGF levels on cisplatin treatment efficacy in patients with non⁃small cell lung cancer [J]. The Journal of Practical Medicine, 2024, 40(24): 3452-3457. |
[4] | Xiao XIAO,Fangyi LONG,Gang. WANG. Dual role and new strategies of pyroptosis in cancer therapy [J]. The Journal of Practical Medicine, 2024, 40(23): 3419-3426. |
[5] | Xinpan LI,Yi FANG,Jun QIU. Predictive value of CD3+/CD4+T lymphocyte level and neutrophil to lymphocyte ratio in radiation pneumonia [J]. The Journal of Practical Medicine, 2024, 40(20): 2923-2928. |
[6] | Xueyan HU,Fanliang MENG,Juanjuan. DONG. Prognostic analysis of patients with bone metastases from primary non-small cell lung cancer with different pathologic staging [J]. The Journal of Practical Medicine, 2024, 40(16): 2316-2325. |
[7] | Shengfang YUAN,Bu WANG,Baoli XIANG,Jianqing ZHAO,Jingjing SHEN,Zhihua. ZHANG. Prediction of immune therapy efficacy and prognosis for advanced non-small cell lung cancer using peripheral blood circulation tumor DNA [J]. The Journal of Practical Medicine, 2024, 40(15): 2110-2115. |
[8] | Yuting LI,Qilu YAN,Qibin. SONG. Molecular basis of variability in EGFR⁃targeted therapy response in non⁃small cell lung cancer [J]. The Journal of Practical Medicine, 2024, 40(15): 2166-2171. |
[9] | Ruiwen CHENG,Ruobing HAO,Ping LI,Kun ZHANG,Liping DENG,Yaheng CAO,Lin SU,Hongrong. SHEN. Clinical efficacy of CalliSpheres drug⁃loaded microspheres versus blank microspheres in the treatment of advanced non⁃small cell lung cancer by transarterial chemoembolization [J]. The Journal of Practical Medicine, 2024, 40(1): 32-37. |
[10] | Yue XU,Yanbin ZHANG,Shan. SU. RNA sequencing⁃based research on the immune regulation mechanism of C⁃MET in lung cancer [J]. The Journal of Practical Medicine, 2024, 40(1): 7-12. |
[11] |
YE Hua, WU Jingbo..
Interstitial brachytherapy in locally advanced non⁃small cell lung cancer [J]. The Journal of Practical Medicine, 2023, 39(5): 525-532. |
[12] |
XU Lu, HUANG Liyou, WANG Yanhua, WEN Linchun..
Efficacy and safety ofPD ⁃ 1 inhibitor combined with brain radiotherapy for brain metastases in patients with pan⁃negative non⁃small cell lung cancer [J]. The Journal of Practical Medicine, 2022, 38(24): 3100-3105. |
[13] |
CHANG Hao, HE Dongjie, YU Dequan, ZHANG Zishen, ZHAO Pinting, QI Yuhong, SHAO Qiuju, YUAN Can⁃ liang..
An analysis on recurrence pattern and survival in patients undergoing IMRT for medulloblastoma [J]. The Journal of Practical Medicine, 2021, 37(21): 2786-2790. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||